Ben Z. Stanger, MD, PhD, University of Pennsylvania
Ben Z. Stanger, MD, PhD
Dr. Stanger's laboratory uses genetically engineered mice to understand how cell identity is maintained in vivo. They study cellular plasticity in the context of liver regeneration, diabetes, and cancer - where epithelial-to-mesenchymal transition promotes cell invasion and metastasis. In addition, they have a strong interest in tumor immunology, and the mechanisms by which tumor cells influence their microenvironment.
Products
References
- Li, Jinyang, et al. "Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy." Immunity 49.1 (2018): 178-193.
